Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2218]

Ibrutinib recieves additional European Commission approval for the treatment of Waldenström’s Macroglobulinemia

Ibrutinib recieves additional European Commission approval for the treatment of Waldenström’s Macroglobulinemia

Baroness Delyth Morgan appointed as chair of the National Cancer Research Institute

Baroness Delyth Morgan appointed as chair of the National Cancer Research Institute

NICE’s new symptom–based approach will help to save thousands of lives from cancer

NICE’s new symptom–based approach will help to save thousands of lives from cancer

Cancer charity welcomes update guideline from NICE on colorectal cancer

Cancer charity welcomes update guideline from NICE on colorectal cancer

European Commission approves nivolumab for first-line and previously-treated advanced melanoma patients

European Commission approves nivolumab for first-line and previously-treated advanced melanoma patients

NICE reject enzalutamide for advanced prostate cancer before chemotherapy

NICE reject enzalutamide for advanced prostate cancer before chemotherapy

Rolling submission of Biologic License Application initiated for daratumumab with US FDA for multiple myeloma

Rolling submission of Biologic License Application initiated for daratumumab with US FDA for multiple myeloma

Oral cancer therapy combination prevents progression of advanced melanoma for over a year

Oral cancer therapy combination prevents progression of advanced melanoma for over a year

Challenges ahead for European clinical trials

Challenges ahead for European clinical trials

Trabectedin improves disease control in patients with advanced soft tissue sarcoma

Trabectedin improves disease control in patients with advanced soft tissue sarcoma

More from ecancer